From February 5, 2024 to March 31, 2024, the company has repurchased 200,000 shares, representing 0.25% for CNY 9.43 million. With this, the company has completed the repurchase of 200,000 shares, representing 0.25% for CNY 9.43 million under the buyback announced on February 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.46 CNY | -1.00% | -3.40% | -27.58% |
May. 13 | Suzhou Highfine Biotech Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
Apr. 25 | Suzhou Highfine Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.58% | 647M | |
+3.49% | 104B | |
-8.98% | 60.79B | |
+82.86% | 51.13B | |
+14.68% | 38.21B | |
-0.68% | 30.75B | |
+10.20% | 19.83B | |
+10.56% | 16.5B | |
+7.90% | 13.82B | |
-2.61% | 13.33B |
- Stock Market
- Equities
- 301393 Stock
- News Suzhou Highfine Biotech Co., Ltd.
- Tranche Update on Suzhou Highfine Biotech Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.